# A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma

> **NCT00642239** · PHASE4 · UNKNOWN · sponsor: **Shandong Luye Pharmaceutical Co., Ltd.** · enrollment: 48 (estimated)

## Conditions studied

- Esophageal Carcinoma

## Interventions

- **DRUG:** placebo
- **DRUG:** Sodium Glycididazole

## Key facts

- **NCT ID:** NCT00642239
- **Lead sponsor:** Shandong Luye Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-04
- **Primary completion:** 2008-12
- **Final completion:** 2009-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2008-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00642239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00642239, "A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00642239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*